Low-dose vs. standard-dose alteplase for acute ischemic stroke: a real-world single-center retrospective study
ObjectivesTo investigate the real-world usage patterns and clinical outcomes of low-dose (0.6 mg/kg) versus standard-dose (0.9 mg/kg) intravenous alteplase in patients with acute ischemic stroke (AIS).MethodsThis single-center retrospective study included 707 patients with AIS who received intraveno...
| Published in: | Frontiers in Neurology |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-10-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1651307/full |
